Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical cannabidiol-based treatment in psoriasis patients
TCTR20210529001Phase 4Not yet recruiting
- Sponsor
- King Chulalongkorn Memorial Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cannabidiol in psoriasis, sponsored by King Chulalongkorn Memorial Hospital. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
psoriasis
Beyond the preview
Go deeper on TCTR20210529001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210529001.